Invention Publication
- Patent Title: BELVARAFENIB FOR USE IN TREATMENT OF BRAIN CANCERS
-
Application No.: US18549622Application Date: 2022-03-08
-
Publication No.: US20240173329A1Publication Date: 2024-05-30
- Inventor: Joanne Adamkewicz , Michael John Dolton , Shiva Malek , Piia Thomas , Jennifer Eng-Wong , Yibing Yan , Young Hoon KIM , Young Gil AHN , Yu Yon KIM
- Applicant: Genentech, Inc. , Hoffmann-La Roche Inc. , Hanmi Pharm. Co., Ltd.
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.,Hoffmann-La Roche Inc.,Hanmi Pharm. Co., Ltd.
- Current Assignee: Genentech, Inc.,Hoffmann-La Roche Inc.,Hanmi Pharm. Co., Ltd.
- Current Assignee Address: US CA South San Francisco
- International Application: PCT/US22/19273 2022.03.08
- Date entered country: 2023-09-08
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K31/4523 ; A61P35/04
Abstract:
Provided are methods for the use of belvarafenib to treat brain cancer including metastatic brain cancer carrying a BRAF mutation, a NRAS mutation, a KRAS mutation, or a combination thereof.
Information query
IPC分类:
